Table 1.
Diverse actions of NO in cancer: tumor promoting role of NO
|
Tumor promoting role | |
|---|---|
| Role of nitric oxide (NO) | Mechanism by which NO acts |
| Genotoxicmechanisms |
Formation of toxic and mutagenic species |
| Direct modification of DNA– strand breaks, oxidation and deamination of nucleic acids | |
| Inhibition of systems required to repair DNA lesions | |
| Antiapoptotic effects |
GC to AT mutations in p53– loss of its repressor activity |
| Direct inhibition of caspase activity through s-nitrosylation of the cysteine thiol | |
| Inhibition of cytochrome C release | |
| Increase in Bcl-2 expression | |
| Suppression of ceramide generation | |
| Activation of cyclooxygenase | |
| Induces and promotes angiogenesis (iNOSandeNOS) |
Dilatation of arteriolar vessels by eNOS |
| VEGF release and NO stimulation of hyperpermeability of vascular endothelium | |
| Increased production of PGE2 resulting in increased tumor vasculature permeability | |
| |
Activation of COX-2 which stimulates production of proangiogenic factors and prostaglandins |
| Limits host immune response against tumor |
Suppression of proliferation and infiltration of leukocytes |
| Low leukocyte-endothelial interaction | |
| Promotes metastasis | Promotes lymphangiogenesis and spread to lymph nodes possibly through involvement of VEGF-C |
| Upregulation of MMP-2 and −9 | |
| Downregulation of TIMP-2 and-3 | |